Medtronic announces expanded CE Mark indication for Affera™ Mapping and Ablation System and Sphere-9™ Catheter for treatment of ventricular arrhythmias
Go back to Medtronic announces expanded CE Mark indication for Affera™ Mapping and Ablation System and Sphere-9™ Catheter for treatment of ventricular arrhythmias| Medtronic Inc. (NYSE: MDT) | Delayed: 92.81 -1.36 (1.44%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $94.17 | 52 Week High | $89.27 | |||
| Open | $93.25 | 52 Week Low | $71.03 | |||
| Day High | $93.30 | P/E | 26.37 | |||
| Day Low | $91.42 | EPS | $3.52 | |||
| Volume | 5,771,613 | |||||
